BARCLAYS PLC - INNATE PHARMA S A ownership

INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 1 filers reported holding INNATE PHARMA S A in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of INNATE PHARMA S A
ValueSharesWeighting
Q3 2023$10.0%4120.0%0.00%
Q2 2023$10.0%4120.0%0.00%
Q1 2023$1
-50.0%
4120.0%0.00%
Q4 2022$2412
+235.0%
0.00%
Q3 2022$0
-100.0%
123
-94.4%
0.00%
Q2 2022$6,000
-45.5%
2,179
-36.1%
0.00%
Q1 2022$11,0003,4110.00%
Other shareholders
INNATE PHARMA S A shareholders Q4 2023
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 4,545,454$29,273,0002.64%
Rubric Capital Management LP 1,350,000$8,694,0000.98%
Maven Securities LTD 130,000$836,0000.08%
OXFORD ASSET MANAGEMENT LLP 44,226$284,0000.01%
OLD MISSION CAPITAL LLC 13,038$84,0000.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 200,000$1,288,0000.00%
FNY Investment Advisers, LLC 1,795$11,0000.00%
WELLINGTON MANAGEMENT GROUP LLP 1,353,773$8,705,0000.00%
MILLENNIUM MANAGEMENT LLC 74,242$477,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of INNATE PHARMA S A shareholders